Effects of intracerebroventricular injections of free fatty acids, lysophospholipids, or platelet activating factor in a mouse model of orofacial pain

Experimental Brain Research

Volumn 174, Issue 4, 2006, Pages 781-785

  Vahidy, Wajiha H ^a   Ong, Wei Yi ^a   Farooqui, Akhlaq A ^b   Yeo, Jin Fei ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Allodynia; Arachidonic acid; Hyperalgesia; Lysophosphatidic acid; Lysophosphatidylcholine; Oleic acid; Orofacial pain; Platelet activating factor

Indexed keywords

ARACHIDONIC ACID; CARRAGEENAN; FATTY ACID; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPID; OLEIC ACID; THROMBOCYTE ACTIVATING FACTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; INJECTION SITE; MALE; MOUSE; NONHUMAN; OROFACIAL PAIN; PAIN; PRIORITY JOURNAL; TIME;

ANIMALS; CARRAGEENAN; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FACIAL PAIN; FATTY ACIDS, NONESTERIFIED; INJECTIONS, INTRAVENTRICULAR; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED BALB C; PAIN MEASUREMENT; PLATELET ACTIVATING FACTOR; TIME FACTORS;

EID: 33749361800     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00221-006-0672-7     Document Type: Article

References (17)

1. 2 in neurological disorders. Springer, Berlin Heidelberg New York (in press)
2. Fuentes E, Nadal A, McNaughton PA (1999) Lysophospholipids trigger calcium signals but not DNA synthesis in cortical astrocytes. Glia 28:272-276
3. Inoue M, Rashid MH, Fujita R, Contos JJ, Chun J, Ueda H (2004) Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 10:712-718
4. Ji RR, Kohno T, Moore KA, Woolf CJ (2003) Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26:696-705
5. 2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron 41:323-335
6. Kugelberg E, Lindblom U (1959) Mechanism of pain in trigeminal neuralgia. J Neurol Neurosurg Psychiatry 22:36-43
7. Lee EY, Chen H, Shephered KR, Lamango NS, Soliman KFA, Charlton CG (2004) Inhibitory effects of lysophosphatidylcholine on dopaminergic system. Neurochem Res 29:1333-1342
8. 2. Br J Pharmacol 144:940-952
9. Malan TP, Porreca F (2005) Lipid mediators regulating pain sensitivity. Prostaglandins Other Lipid Mediat 77:123-30
10. Moolenaar WH, van Meeteren LA, Giepmans BN (2004) The ins and outs of lysophosphatidic acid signaling. Bioessays 26:870-881
11. Morita K, Morioka N, Abdin J, Kitayama S, Nakata Y, Dohi T (2004) Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice. Pain 111:351-359
12. Murillo-Rodriguez E, Sanchez-Alavez M, Navarro L, Martinez-Gonzalez D, Drucker-Colin R, Prospero-Garcia O (1998) Anandamide modulates sleep and memory in rats. Brain Res 812:270-274
13. Ng CH, Ong WY (2001) Increased expression of gamma-aminobutyric acid transporters GAT-1 and GAT-3 in the spinal trigeminal nucleus after facial carrageenan injections. Pain 92:29-40
14. 2 in noradrenaline release from cerebral cortical synaptosomes. J Pharm Pharmacol 41:450-458
15. Vos BP, Strassman AM, Maciewicz RJ (1994) Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve. J Neurosci 14:2708-2723
16. Weltzien HU (1979) Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim Biophys Acta 559:259-287
17. 2 inhibitors modulates allodynia after facial carrageenan injection in mice. Pain 112:148-155